These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24043603)

  • 1. MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression.
    Song Y; Mu L; Han X; Li Q; Dong B; Li H; Liu X
    J Neurooncol; 2013 Dec; 115(3):381-90. PubMed ID: 24043603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.
    Gao Y; Yu H; Liu Y; Liu X; Zheng J; Ma J; Gong W; Chen J; Zhao L; Tian Y; Xue Y
    Cell Physiol Biochem; 2018; 45(1):131-147. PubMed ID: 29310118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells.
    Xu D; Ma P; Gao G; Gui Y; Niu X; Jin B
    Tumour Biol; 2015 Sep; 36(10):7743-53. PubMed ID: 25936342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
    Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
    Wang S; Akhtar J; Wang Z
    Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA TPT1-AS1 downregulates the microRNA-770-5p expression to inhibit glioma cell autophagy and promote proliferation through STMN1 upregulation.
    Jia L; Song Y; Mu L; Li Q; Tang J; Yang Z; Meng W
    J Cell Physiol; 2020 Apr; 235(4):3679-3689. PubMed ID: 31637705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR‑141 inhibits glioma vasculogenic mimicry by controlling EphA2 expression.
    Li G; Huang M; Cai Y; Ke Y; Yang Y; Sun X
    Mol Med Rep; 2018 Aug; 18(2):1395-1404. PubMed ID: 29901110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
    Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
    Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRRC4 inhibits the proliferation of human glioma cells by modulating the expression of STMN1 and microtubule polymerization.
    Wang R; Wang Z; Yang J; Liu X; Wang L; Guo X; Zeng F; Wu M; Li G
    J Cell Biochem; 2011 Dec; 112(12):3621-9. PubMed ID: 21809374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let-7a suppresses glioma cell proliferation and invasion through TGF-β/Smad3 signaling pathway by targeting HMGA2.
    Li Y; Zhang X; Chen D; Ma C
    Tumour Biol; 2016 Jun; 37(6):8107-19. PubMed ID: 26715270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-κB activity.
    Xia H; Yan Y; Hu M; Wang Y; Wang Y; Dai Y; Chen J; Di G; Chen X; Jiang X
    Neuro Oncol; 2013 Apr; 15(4):413-22. PubMed ID: 23243056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
    Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G
    Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.
    Wang K; Wang X; Zou J; Zhang A; Wan Y; Pu P; Song Z; Qian C; Chen Y; Yang S; Wang Y
    Neuro Oncol; 2013 May; 15(5):578-88. PubMed ID: 23416699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R.
    Guo T; Feng Y; Liu Q; Yang X; Jiang T; Chen Y; Zhang Q
    Tumour Biol; 2014 Nov; 35(11):11269-75. PubMed ID: 25117070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
    Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
    Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma.
    Chen L; Zhang W; Yan W; Han L; Zhang K; Shi Z; Zhang J; Wang Y; Li Y; Yu S; Pu P; Jiang C; Jiang T; Kang C
    Carcinogenesis; 2012 Nov; 33(11):2276-82. PubMed ID: 22871495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma.
    Tian Y; Nan Y; Han L; Zhang A; Wang G; Jia Z; Hao J; Pu P; Zhong Y; Kang C
    Int J Oncol; 2012 Apr; 40(4):1105-12. PubMed ID: 22179124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer.
    Kang W; Tong JH; Chan AW; Lung RW; Chau SL; Wong QW; Wong N; Yu J; Cheng AS; To KF
    PLoS One; 2012; 7(3):e33919. PubMed ID: 22470493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma.
    Cheng Z; Wang HZ; Li X; Wu Z; Han Y; Li Y; Chen G; Xie X; Huang Y; Du Z; Zhou Y
    J Exp Clin Cancer Res; 2015 Mar; 34(1):27. PubMed ID: 25888093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.
    Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC
    Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.